International Journal of Antimicrobial Agents
Volume 36, Issue 6 , Pages 485-490 , December 2010

Intravesical gentamicin for recurrent urinary tract infection in patients with intermittent bladder catheterisation

  • C. van Nieuwkoop

      Affiliations

    • Department of Infectious Diseases, Leiden University Medical Center, C5-P, P.O. Box 9600, 2300 RC Leiden, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 71 526 2613; fax: +31 71 526 6758.
    • ,
  • P.L. den Exter

      Affiliations

    • Department of Infectious Diseases, Leiden University Medical Center, C5-P, P.O. Box 9600, 2300 RC Leiden, The Netherlands
    • ,
  • H.W. Elzevier

      Affiliations

    • Department of Urology, Leiden University Medical Center, The Netherlands
    • ,
  • J. den Hartigh

      Affiliations

    • Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, The Netherlands
    • ,
  • J.T. van Dissel

      Affiliations

    • Department of Infectious Diseases, Leiden University Medical Center, C5-P, P.O. Box 9600, 2300 RC Leiden, The Netherlands

References 

  1. Lapides J, Diokno AC, Silber SJ, Lowe BS. Clean, intermittent self-catheterization in the treatment of urinary tract disease. J Urol. 1972;107:458–461
  2. Shekelle PG, Morton SC, Clark KA, Pathak M, Vickrey BG. Systematic review of risk factors for urinary tract infection in adults with spinal cord dysfunction. J Spinal Cord Med. 1999;22:258–272
  3. Bakke A, Digranes A, Hoisaeter PA. Physical predictors of infection in patients treated with clean intermittent catheterization: a prospective 7-year study. Br J Urol. 1997;79:85–90
  4. Tenke P, Kovacs B, Bjerklund Johansen TE, Matsumoto T, Tambyah PA, Naber KG. European and Asian guidelines on management and prevention of catheter-associated urinary tract infections. Int J Antimicrob Agents. 2008;31(Suppl. 1):S68–S78
  5. Wyndaele JJ. Complications of intermittent catheterization: their prevention and treatment. Spinal Cord. 2002;40:536–541
  6. Wan J, Kozminski M, Wang SC, Faerber GJ, McGuire EJ, Bloom DA, et al. Intravesical instillation of gentamicin sulfate: in vitro, rat, canine, and human studies. Urology. 1994;43:531–536
  7. Byrt T. How good is that agreement?. Epidemiology. 1996;7:561
  8. European Committee on Antimicrobial Susceptibility Testing. Clinical breakpoints. EUCAST; 2010. http://www.eucast.org/clinical_breakpoints [accessed 3 March 2010].
  9. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J Pelvic Floor Dysfunct. 2010;21:5–26
  10. Harper WE. An appraisal of 12 solutions used for bladder irrigation or instillation. Br J Urol. 1981;53:433–438
  11. Mulcahy JJ, James HE. Management of neurogenic bladder in infancy and childhood. Urology. 1979;13:235–240
  12. Haldorson AM, Keys TF, Maker MD, Opitz JL. Nonvalue of neomycin instillation after intermittent urinary catheterization. Antimicrob Agents Chemother. 1978;14:368–370
  13. Rhame FS, Perkash I. Urinary tract infections occurring in recent spinal cord injury patients on intermittent catheterization. J Urol. 1979;122:669–673
  14. Pearman JW. The value of kanamycin–colistin bladder instillations in reducing bacteriuria during intermittent catheterisation of patients with acute spinal cord injury. Br J Urol. 1979;51:367–374
  15. Anderson RU. Prophylaxis of bacteriuria during intermittent catheterization of the acute neurogenic bladder. J Urol. 1980;123:364–366
  16. McGuire EJ, Savastano JA. Treatment of intractable bacterial cystitis with intermittent catheterization and antimicrobial instillation: case report. J Urol. 1987;137:495–496
  17. Pearman JW, Bailey M, Harper WE. Comparison of the efficacy of ‘Trisdine’ and kanamycin–colistin bladder instillations in reducing bacteriuria during intermittent catheterisation of patients with acute spinal cord trauma. Br J Urol. 1988;62:140–144
  18. Defoor W, Ferguson D, Mashni S, Creelman L, Reeves D, Minevich E, et al. Safety of gentamicin bladder irrigations in complex urological cases. J Urol. 2006;175:1861–1864
  19. Tyagi P, Wu PC, Chancellor M, Yoshimura N, Huang L. Recent advances in intravesical drug/gene delivery. Mol Pharm. 2006;3:369–379
  20. Warren JW, Platt R, Thomas RJ, Rosner B, Kass EH. Antibiotic irrigation and catheter-associated urinary-tract infections. N Engl J Med. 1978;299:570–573
  21. Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:625–663
  22. Chamberlain G, Needham P. The absorption of antibiotics from the bladder. J Urol. 1976;116:172–173
  23. de Jong TP, Donckerwolcke RA, Boemers TM. Neomycin toxicity in bladder irrigation. J Urol. 1993;150:1199
  24. Gerharz EW, Weingartner K, Melekos MD, Varga S, Feiber H, Riedmiller H. Neomycin-induced perception deafness following bladder irrigation in patients with end-stage renal disease. Br J Urol. 1995;76:479–481
  25. Elliott TS, Reid L, Rao GG, Rigby RC, Woodhouse K. Bladder irrigation or irritation?. Br J Urol. 1989;64:391–394

PII: S0924-8579(10)00223-2

doi: 10.1016/j.ijantimicag.2010.05.005

International Journal of Antimicrobial Agents
Volume 36, Issue 6 , Pages 485-490 , December 2010

Article Tools

* Image Usage & Resolution